Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza Vaccines
Investigators at Center for Immunology target influenza vaccines
December 24th, 2008
A new study, 'Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children,' is now available. "The avian influenza A (H5N1) virus is considered to be a potential cause of the next influenza pandemic. Children may be particularly vulnerable to the pandemic virus, and they may react differently than adults to vaccines," scientists in Budapest, Hungary report. "We report the results of the first clinical trial of an H5N1 vaccine in children. Twelve healthy children (mean age ±SD: 12.73 ±2.77 years) received a single dose of 6 microg of the inactivated whole virus vaccine Fluval. Twenty-one days after vaccination, immunogenicity was...
Source: Vaccine Weekly (2008-12-24)
|
